Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F0A1H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,852
Award facts
- Contract value 100% obligated
- $83,852.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 23, 2026, for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This competitive award, valued at $83,852.36 with a firm fixed price structure, has an ultimate completion date of January 26, 2026. The contract was executed without a set-aside designation, indicating open competition. The place of performance is Conshohocken, Pennsylvania, which serves as the corporate headquarters for Amerisourcebergen Drug Corp, a major pharmaceutical distributor providing critical medical products to federal military and veteran healthcare systems.
This delivery order is issued under Amerisourcebergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. This prime IDC vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains, vaccines, syringes, vials, and specialized medical commodities. The award demonstrates the contractor's continued role in the Defense Health Agency's pharmaceutical supply chain and reflects ongoing federal procurement of essential medical products for military treatment facilities and related healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F0A1H?
SPE2DR26F0A1H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F0A1H worth?
The government has obligated $83,852 on SPE2DR26F0A1H.
Is contract SPE2DR26F0A1H an order under another contract?
Yes. SPE2DR26F0A1H is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A1H competed?
The extent of competition for SPE2DR26F0A1H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award